Company | GLAXO | Symbol |
Company Name | Glaxosmithkline (Pak) Ltd. | Company Name |
Sector | Pharma and Bio Tech | Sector |
Avg EPS | Rs 7.18 | Average of past year end EPS's |
Sector Average | Rs 19.88 | Sector average of the above |
Avg EPS FV | Rs 51.15 | Fair Value (DCF) based on average of past year-end EPS's |
EPS | Rs 3.67 | Last four quarters EPS |
Sector Average | Rs 25.46 | Sector average of the above |
EPS FV | Rs 26.14 | Fair Value (DCF) based on last four quarters EPS |
Current Price | Rs 165.45 | Last closing stock price |
Updated | February 2014 | Data Month/Year |
Div | Rs 3.50 | Total dividend paid during last four quarters |
Sector Average | Rs 13.06 | Sector average of the above |
Div FV | Rs 24.93 | Fair value (DD) based on total dividend paid during last four quarters |
Avg Div | Rs 5.50 | Average of yearly dividends paid (including currently paid ones) |
Sector Average | Rs 10.60 | Sector average of the above |
Avg Div FV | Rs 39.17 | Fair value (DD) based on Average of yearly dividends paid (including current) |
Avg | Rs 27.42 | Fair value (averaged of other fair values) |
Upside | -83.43% | Upside potential (in percentage) based on the above Average. |
Div Yield | 2.12% | Dividend yield |
Sector Average | 1.83% | Sector average of the above |
Book Value | Rs 39.62 | Book Value |
Sector Average | Rs 194.32 | Sector average of the above |
FV FCF/S | Rs 18.13 | Fair Value based on free cash flow per share |
Outstanding Shares | 289,515,706 | Number of Outstanding Shares |
Current Assets | Rs 9,404.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 4,772.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs 16.00 | Net Current Asset Value / Share |
NNWC/S | Rs 4.20 | Net Net Working Capital / Share |
Total Assets | Rs 16,243.00 | Currency in Millions of Pakistan Rupees |
Quarter | December 2012 | Financial Report Quarter |
CfO | Rs 2,235.00 | Cash from Operations (Millions of Rs) |
FCF/S | Rs 2.55 | Free Cash Flow per Share |
FCF/S Sector Avg | -2.00 | Sector Average FCF/S |
P/FCF | 64.99 | Price over free cash flow |
P/FCF Sector Avg | 23.94 | Sector Average P/FCF |
P/E | 45.08 | Price over earnings ratio |
P/E Sector Avg | 20.05 | Sector Average P/E |
P/B | 4.18 | Price over book value ratio |
P/B Sector Avg | 4.06 | Sector Average P/B |
PR | 95.37 | Payout Ratio (in %) |
PR Sector Avg | 42.78 | Sector average Payout Ratio (in %) |
D/E Ratio | 41.60 | Debt / Equity ratio (%) |
Sector D/E Ratio | 81.08 | Sector Debt / Equity ratio (%) |
Price Performance | ||
Last Trade Date | 07/02/2014 | |
Last Trade Price | Rs 165.45 | |
3 Months Avg | Rs 143.85 | |
6 Months Avg | Rs 130.09 | |
9 Months Avg | Rs 123.08 | |
12 Months Avg | Rs 111.48 | |
Score | -16 | cumulative +ve's, -ve's from above all |
Buy Scale | -3 | Range -5 to +5 (based on 5 different complex analysis) |
No comments:
Post a Comment